Clinical Trial Update: Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating addition of etanercept and extracorporeal photopheresis to standard graft-versus-host disease prophylaxis in stem cell transpl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Etanercept (etanercept)
• Extracorporeal Photopheresis

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25